A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo

Developing effective therapies against multiple myeloma (MM) is an unresolved challenge. Phosphatidylinositol-3-kinase (PI3K) activation may be associated with tumor progression and drug resistance, and inhibiting PI3K can induce apoptosis in MM cells. Thus, targeting of PI3K is predicted to increas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Glauer, J, Pletz, N, Schön, M, Schneider, P, Liu, N, Ziegelbauer, K, Emmert, S, Wulf, G G, Schön, M P
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2013
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3789203/
https://ncbi.nlm.nih.gov/pubmed/24013662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2013.37
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados